Press Releases & News
International Isotopes, Inc. Announces the Amendment of the Acquisition of the AMICI, Inc. Product Line
IDAHO FALLS, IDAHO, January 9th, 2025. International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce...
International Isotopes, Inc. Announces Exclusive Distributorship of Scintomics Moleculer/Applied Theranostics Technologies GmbH (ATT) Radiosynthesis Modules Throughout the U.S. and Canada
IDAHO FALLS, Idaho and FÜRSTENFELDBRUCK, Germany, January 7, 2025. International Isotopes, a leading provider of medical isotopes and nuclear medicine...
International Isotopes, Inc. Announces Financial Results for Third Quarter of 2024 and First Nine Months of 2024
Company Revenues increased by over $1,000,000, or 34%, for the Third Quarter compared to the prior year. Theranostics Sales increased 42% compared the Third...
International Isotopes, Inc. Announces Joint Venture Agreement to Form PhanQual
IDAHO FALLS, Idaho and MADISON, Wisconsin, September 4th, 2024 -- International Isotopes, Inc. (INIS) and Phantech Medical (Phantech) have entered into a...
International Isotopes, Inc. Announces Financial Results for Second Quarter of 2024 and First Six Months of 2024
Theranostics Sales increased 25% in the Second Quarter, and 16% for the Six Months Ended June 30, 2024. Gross Profit improved to 64%, a 7% increase, for the...
INIS and Alpha Nuclides Sign Strategic Development And Distribution Agreements For China
Idaho Falls, ID, USA and Ningbo, Zhejiang Province, CN – June 6th, 2024 – International Isotopes, Inc. (INIS) and Alpha Nuclide Inc (AN) have entered into a...
International Isotopes, Inc. Announces Financial Results for First Quarter of 2024
Theranostics Products Revenues Increased 8% in the Three Months Ended March 31, 2024. Net Cash Provided By Operating Activities Was Approximately $400,000 in...
INIS to Distribute Nuclear Shields B.V. Products
IDAHO FALLS, IDAHO, May 1,2024. International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is excited to announce that it...
International Isotopes, Inc. Announces Fiscal Results for Fiscal Year 2023
Revenues Increased 10% in the Twelve Months Ended December 31, 2023 versus prior year. Revenue of $12.3 million in the Twelve Months Ended December 31, 2023...
International Isotopes, Inc. to Divest Depleted Uranium Deconversion Assets to American Fuel Resources for $12,500,000 Cash
IDAHO FALLS, IDAHO, February 8,2024. International Isotopes Inc. (OTCQB: INIS) (“International Isotopes,” “INIS” or the “Company”) is pleased to announce that...
International Isotopes, Inc. Announces Fiscal Results for the Third Quarter and First Nine Months of 2023
Revenues Increased 14% in the Nine Months Ended September 30, 2023. Operating Loss Improved 43% in the Nine Months Ended September 30, 2023. Gross Profit...
International Isotopes, Inc. Announces Fiscal Results for the Second Quarter and First Six Months of 2023
Revenues Increased 28% in the Second Quarter. Net Cash Generation from Operations of more than $1,000,000 For The Six Months Ended June 30, 2023. June 30th...








